This inventor holds 1 USPTO granted patent. Top assignee: Nanyang Technological University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations of Jingmei Huang in Neurokinin-1 Receptor Antagonists
Introduction
Jingmei Huang is a notable inventor based in Singapore, recognized for his contributions to the field of pharmacology. He has developed innovative compounds that have significant implications for medical science. His work primarily focuses on neurokinin-1 (NK1) receptor antagonists, which are crucial in various therapeutic applications.
Latest Patents
Jingmei Huang holds a patent for 3-piperidone compounds and their use as neurokinin-1 (NK1) receptor antagonists. The invention specifically relates to (2S)-phenyl-3-piperidone and its synthesis method. The synthesized 3-piperidone compounds are noted for their potency as NK1 receptor antagonists, showcasing their potential in treating various conditions.
Career Highlights
Jingmei Huang is affiliated with Nanyang Technological University, where he continues to engage in research and development. His academic background and ongoing projects contribute to advancements in medicinal chemistry and pharmacology.
Collaborations
Some of his notable coworkers include Teck Peng Loh and Peng Wang, who collaborate with him on various research initiatives. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Jingmei Huang's work in developing 3-piperidone compounds represents a significant advancement in the field of neurokinin-1 receptor antagonists. His contributions are poised to impact therapeutic strategies in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile